Wide Ranks

MTEM

Molecular Templates, Inc.

0.3744

Top Statistics
Market Cap 2 M Forward PE -0.1593 Revenue Growth -91.70 %
Current Ratio 1.56 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -61.35 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.2770 Enterprise / Revenue 0.1510 Price To Sales Trailing12 Months 0.0968
Profitability
Profit Margins -61.35 % Operating Margins -1450.35 %
Balance Sheet
Total Cash 9 M Total Cash Per Share 1.47 Total Debt 11 M
Total Debt To Equity 155.07 Current Ratio 1.56 Book Value Per Share 1.08
All Measures
Short Ratio 10.00 % Message Board Id finmb_27892633 Shares Short Prior Month 251356
City Austin Uuid 50b78e85-ce75-3e81-80ea-f799bd42f2e1 Previous Close 0.3700
First Trade Date Epoch Utc 1 B Book Value 1.08 Beta 1.22
Total Debt 11 M Volume 2 M Price To Book 0.3467
Last Split Date 1 B Fifty Two Week Low 0.3000 Total Cash Per Share 1.47
Total Revenue 25 M Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins -1450.35 % Net Income To Common -15626000
Short Percent Of Float 0.5324 Implied Shares Outstanding 6 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 38 M Average Volume10days 38 M
Total Cash 9 M Next Fiscal Year End 1 B Revenue Per Share 4.54
Held Percent Insiders 0.0396 Ebitda Margins -54.44 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.3700
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.7854
Open 0.4200 Free Cashflow -17498624 State TX
Dividend Yield 0.00 % Return On Assets -0.3788 Time Zone Short Name EST
Trailing Eps -3.05 Day Low 0.3681 Address1 9301 Amberglen Boulevard
Shares Outstanding 6 M Price Hint 4 Target High Price 0.0000
Website https://www.mtem.com 52 Week Change -0.9242 Average Volume 10 M
Forward Eps -2.35 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 136.10 % Last Split Factor 1:15 Regular Market Day High 0.4200
Is_sp_500 False Profit Margins -61.35 % Debt To Equity 155.07
Fifty Two Week High 5.25 Day High 0.4200 Shares Short 2 M
Regular Market Open 0.4200 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue 0.1510 Revenue Growth -91.70 % Shares Percent Shares Out 0.3735
Operating Cashflow -23924000 Currency USD Time Zone Full Name America/New_York
Market Cap 2 M Is_nasdaq_100 False Zip 78729
Quote Type EQUITY Industry Biotechnology Long Name Molecular Templates, Inc.
Regular Market Day Low 0.3681 Held Percent Institutions 0.3501 Current Price 0.3744
Address2 Suite 100 Enterprise To Ebitda -0.2770 Financial Currency USD
Current Ratio 1.56 Gross Margins -14.75 % Industry Disp Biotechnology
Country United States Float Shares 4 M Two Hundred Day Average 1.54
Enterprise Value 3 M Price To Sales Trailing12 Months 0.0968 Forward PE -0.1593
Regular Market Volume 2 M Ebitda -13865000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States.

The company develops therapies through its proprietary biologic drug platform technology (ETB).

It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors.

The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets.

Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.